Nancy Prince
About Nancy Prince
Nancy Prince is the District Business Manager at Bristol-Myers Squibb in Cincinnati, OH, with over two decades of experience in oncology sales management.
Current Position at Bristol-Myers Squibb
Nancy Prince serves as the District Business Manager at Bristol-Myers Squibb in Cincinnati, OH. She started this role in January 1998 and has since been responsible for overseeing a team of oncology sales specialists across five mid-South states. Her responsibilities include driving sales, ensuring effective team management, and strategizing to meet the company's oncology sales targets.
Previous Roles at Bristol-Myers Squibb
Before becoming the District Business Manager, Nancy Prince worked as a Sales Trainer at Bristol-Myers Squibb from 1997 to 1998. Prior to that, she served as a Sales Representative from 1989 to 1997. In these roles, she developed her expertise in sales training and oncology sales, laying the groundwork for her current managerial position.
Experience in Oncology Sales
Nancy Prince has over two decades of experience in oncology sales management. Her specialization includes various areas of oncology, such as breast cancer, colorectal cancer (CRC), head and neck cancer, and leukemia. This extensive experience has equipped her with the skills needed to effectively guide and support her sales team in achieving their goals.
Educational Background
Nancy Prince holds multiple degrees. She earned her RN from Beth Israel Medical Center School of Nursing, a BA in Psychology and Theater from the City University of New York-Hunter College, and an RN and MSW in Nursing and Social Work from the University of North Carolina at Chapel Hill. This diverse educational background complements her professional expertise.
Early Career at Reed and Carnrick Pharmaceuticals
Nancy Prince began her career at Reed and Carnrick Pharmaceuticals as a Sales Representative, where she worked from 1985 to 1989. This role provided her with essential sales experience and set the stage for her future career progression in the pharmaceutical industry, eventually leading to her long-term tenure at Bristol-Myers Squibb.